Abstract: Disclosed is a layout structure of a 10T NOR-type CAM including a first CAM cell, a second CAM cell, a third CAM cell, and a fourth CAM cell, in which the first CAM cell and the third CAM cell share search line 1 (SL1) and bit line 1 (BL1), and the second CAM cell and the fourth CAM cell share SL0 and BL0, the first CAM cell and the second CAM cell share match line 1 (ML1) and word line 1 (WL1), and the third CAM cell and the fourth CAM cell share ML0 and WL0, and an active contact is shared between the first CAM cell and the third CAM cell and between the second CAM cell and the fourth CAM cell share.

Abstract: The present disclosure provides for the diagnosis and prediction of neuromyelitis optica (NMO) in a subject. It also provides for treatment of multiple sclerosis (MS) in a subject.

Abstract: In an embodiment a method for preparing a laminate includes forming a cured film by coating a source material composition including a polymer for a base layer and an inorganic particle for forming a pore, obtaining a porous base layer having a spherical pore derived from the inorganic particle by removing the inorganic particle from the cured film through an etching process and forming a coating layer, which has a repeated pattern, on a surface of the porous base layer.

Abstract: A caliper type device is provided for identifying the cranial midline on a patient. The device includes a pair of arms have first ends for receipt in a patients ears, and opposite, pivotally connected second ends which allow the arms to open and close to fit to different sized heads of various patients. A housing at the second end of the arms holds a laser pointer or other tool for identifying the cranial midline after the device is positioned on the patients head.

Abstract: Ultrasound systems and methods are provided using mass characterization frequency methods that provide for predicting benign or malignant lesions, a response to treatment, tumor grading, and/or the expressions of immunohistochemical biomarkers, which are currently used for breast cancer classification and hormone therapy determination. The systems and methods are based on the shear wave parameter, mass characteristic frequency. The status of malignancy, treatment response, grade, and/or each immunohistochemical biomarker may be determined based on a corresponding mass characteristic frequency threshold.

Abstract: A combustion method is disclosed, which includes the steps of mixing fuel and an oxidizer into a mixture, wherein fuel originates from a fuel manifold and the oxidizer originates from an oxidizer manifold, and combusting the mixture in a combustion chamber, the fuel manifold, the oxidizer manifold, and the combustion chamber forming parts of an injector assembly wherein each of the fuel and oxidizer manifolds communicates with the combustion chamber via a plurality of dedicated radially disposed Tesla valves around the combustion chamber each via a corresponding port with only one Tesla valve between the fuel manifold and the corresponding port on the combustion chamber and with only one Tesla valve between the oxidizer manifold and the corresponding port on the combustion chamber, wherein the plurality of Tesla valves substantially eliminate reverse flow of exhaust gases from the combustion chamber back to the fuel manifold or the oxidizer manifold.

Abstract: Techniques include receiving a treatment plan for a subject, including a body outline, a position on a couch, and, for each gantry angle, a couch angle an isocenter and target volumes to which a radiation source is directed. A perspective transform matrix is based on projected coordinates of reference points from a digital image projector onto each different plane perpendicular to a beam from the radiation source at different distances. Two-dimensional spot positions for a gantry and couch angle are determined based on the treatment plan. A group of spot positions are determined based on a common distance from the radiation source to the body outline. Illuminated spots on a projection image are determined based on the group and the perspective transform matrix closest to the common distance. The projection image is projected from the image projector onto the subject on the couch.

Abstract: A method for producing a screw foundation for securing elements in the ground, provides a cylindrical tube as an initial form and a conical front portion tapering to an insertion tip is then molded on to the cylindrical tube using a non-cutting process, the front portion being provided at least in some regions with a thread-like contour for screwing into the ground. An inner contour for a screwing tool is formed integrally in a rear end of the tube by flow forming, and the front portion and the thread-like contour are formed exclusively by flow forming.

Abstract: Provided herein is a nanoparticle for drug delivery, wherein the nanoparticle comprises a hyperbranched polyester (HBPE) nanoparticle having a hydrophobic interior, polyglutamate folate ligands conjugated to the nanoparticle, and one or more PET detectable isotopes. Also provided herein are methods of using thereof.

Abstract: Provided are methods and apparatus for environment-adaptive robotic disinfecting. In an example, provided is a method that can include (i) creating, from digital images, a map of a structure; (ii) identifying a location of a robot in the structure; (iii) segmenting, using a machine learning-based classifying algorithm trained based on object affordance information, the digital images to identify potentially contaminated surfaces within the structure; (iv) creating a map of potentially contaminated surfaces within the structure; (v) calculating a trajectory of movement of the robot to move the robot to a location of a potentially contaminated surface in the potentially contaminated surfaces; and (vi) moving the robot along the trajectory of movement to position a directional decontaminant source adjacent to the potentially contaminated surface. Other methods, systems, and computer-readable media are also disclosed.

Abstract: The embodiments described herein relate generally to medical devices that measure vital signs, and more particularly to wearable wireless devices that collect multiple simultaneous vital signs, and systems and methods for compressing the sensor data into a matrix representation to facilitate collecting, transmitting, processing, and displaying vital sign data.

Abstract: Disclosed herein are novel compounds that are Ras inhibitors. Also disclosed are compositions comprising the compounds and methods of using the compounds in treating various diseases.

Abstract: A data processing method and apparatus using a neural network, and an electronic device including the data processing apparatus. The data processing method includes identifying an operator that selects one of a plurality of execution paths for a portion of the neural network while sequentially executing layers included in the neural network, selecting a specific execution path, from among the plurality of execution paths, based on a remaining time that is left for an inference of the neural network, and obtaining a result of the inference of the neural network through the specific execution path.

Abstract: The present invention relates to a bio-electrode having improved conductivity, flexibility and bio-compatibility, and a method of manufacturing the same. Specifically, the present invention relates to a conductive polymer bio-electrode including nano-porous permeable membrane, based on a bio-compatible polymer material having a plurality of pores and an improved surface area based on a PDMS device having a low mechanical strength and an excellent bio-compatibility, bio-signal transmission patterning, and a gold coating layer and has an excellent bio-compatibility and low rejection response while having a conductivity similar to that of a bio-electrode configured with a metal material of the related art. Therefore, the conductive polymer bio-electrode of the present invention is expected to be able to replace a bio-electrode configured with a metal material by which the bio-signal transmission efficiency is degraded due to a high bio-incompatibility.

Abstract: A display device includes: a display panel including a sensor area and a display area, where the display panel includes an upper surface and a lower surface opposite to the upper surface; and a discoloration sensor layer overlapping the sensor area, where discoloration sensor layer is disposed on one of the upper surface of the display panel and the lower surface of the display panel, and discolored when exposed to a target material. A first through portion is defined through the display panel from the upper surface to the lower surface of the display panel, and the discoloration sensor layer overlaps the first through portion.

Abstract: Embodiments of the present disclosure provide methods, apparatus, systems, and computer program products for using an image of an integrated circuit (IC) including a plurality of cells to locate one or more target cells within the IC. Accordingly, in various embodiments, a footprint for each cell of the plurality of cells is encoded to transform the image of the IC into a two-dimensional string matrix. A string search algorithm is then applied on each encoded dopant region found in the two-dimensional string matrix using an encoded target layout cell to identify one or more candidate regions of interest within the image. Finally, a mask window is slid over each candidate region of interest while performing matching using match criteria to identify any target cells in the one or more target cells that are located within the candidate region of interest.

Abstract: The current invention provides a recombinant bacterium, the recombinant bacterium being genetically modified to synthesize surface layer protein A (SlpA). Efficacious therapies for a subject suffering from an inflammation mediated disease are also provided. The methods of the current invention comprise administering to a subject in need thereof a therapeutically effective amount of the recombinant bacterium, for example L. lactis cells, or a therapeutically effective amount of the isolated SlpA. The recombinant bacteria cells or SlpA isolated from the recombinant bacteria can be in a pharmaceutical composition comprising a pharmaceutically acceptable carrier and/or excipient.

Abstract: A complex light modulator including a first polarization plate, a second polarization plate provided, an amplitude modulator provided between the first polarization plate and the second polarization plate, a phase modulator provided between the amplitude modulator and the second polarization plate, and color filters provided between the amplitude modulator and the phase modulator.

Abstract: The present invention relates to a pharmaceutical composition for treating gout and a gout treatment kit. According to an embodiment of the present invention, a pharmaceutical composition for treating gout comprising a probe containing at least one or more peptides specifically coupled to a monosodium urate (MSU) crystals and a first enzyme which is coupled to the probe and reacts with the target MSU crystal coupled to the probe or urea of surrounding joint fluid to remove the target MSU crystal is provided.

Abstract: A composition contains, as an effective component, theasinensin A, an enantiomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof. The composition has an excellent stability and provides wrinkle-reducing or skin elasticity-enhancing benefits, and skin-brightening benefits by containing theasinensin A, an enantiomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, as an effective component.